| [1] |
Forde CT, Karri SK, Young AM, et al. Predictive markers in traumatic brain injury: opportunities for a serum biosignature[J].Br J Neurosurg,2014,28(1):8-15.
|
| [2] |
Mondello S, Muller U, Jeromin A, et al. Blood- based diagnostics of traumatic brain injuries[J]. Expert Rev Mol Diagn,2011,11(1):65-78.
|
| [3] |
Han K,Mac Donald CL,Johnson AM,et al.Disrupted modular organization of resting-state cortical functional connectivity in U.S. military personnel following concussive'mild blast-related traumatic brain injury[J].Neuroimage,2014,84:76-96.
|
| [4] |
Rohlwink UK, Figaji AA. Biomarkers of brain injury in cerebral infections[J].Clin Chem,2014,60(6):823-834.
|
| [5] |
Mondello S, Robicsek SA, Gabrielli A, et al. aII- spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients[J]. J Neurotrauma, 2010, 27(7):1203-1213.
|
| [6] |
Brown AF, Cullen L, Than M. Future developments in chest pain diagnosis and management[J]. Med Clin North Am, 2010,94(2):375-400.
|
| [7] |
Dash PK, Zhao J, Hergenroeder G, et al. Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury[J]. Neurotherapeutics, 2010, 7(1):100-114.
|
| [8] |
Mondello S, Linnet A, Buki A, et al. Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury[J]. Neurosurgery, 2012, 70(3):666-675.
|
| [9] |
Nishiyama H, Knopfel T, Endo S, et al. Glial protein S100B modulates long-term neuronal synaptic plasticity[J]. Proc Natl Acad Sci U S A,2002,99(6):4037-4042.
|
| [10] |
Bechtel K, Frasure S, Marshall C, et al. Relationship of serum S100B levels and intracranial injury in children with closed head trauma[J].Pediatrics,2009,124(4):e697-e704.
|
| [11] |
Liu MC, Akle V, Zheng W, et al. Extensive degradation of myelin basic protein isoforms by calpain following traumatic brain injury[J].J Neurochem,2006,98(3):700-712.
|
| [12] |
Kovesdi E, Luckl J, Bukovics P, et al. Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics[J]. Acta Neurochir (Wien), 2010,152(1):1-17.
|
| [13] |
Xiong Z, O'Hanlon D, Becker LE, et al. Enhanced calcium transients in glial cells in neonatal cerebellar cultures derived from S100B null mice[J].Exp Cell Res,2000,257(2):281-289.
|
| [14] |
Zurek J, Fedora M. The usefulness of S100B, NSE, GFAP,NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury[J]. Acta Neurochir(Wien),2012,154(1):93-103.
|
| [15] |
Berger RP. The use of serum biomarkers to predict outcome after traumatic brain injury in adults and children[J]. J Head Trauma Rehabil,2006,21(4):315-333.
|
| [16] |
Morochovic R,Racz O,Kitka M,et al.Serum S100B protein in early management of patients after mild traumatic brain injury[J].Eur J Neurol,2009,16(10):1112-1117.
|
| [17] |
Honda M, Tsuruta R, Kaneko T, et al. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase[J].J Trauma,2010,69(1):104-109.
|
| [18] |
Bohmer AE, Oses JP, Schmidt AP, et al. Neuron- specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury[J].Neurosurgery,2011,68(6):1624-1630.
|
| [19] |
Kovesdi E, Luckl J, Bukovics P, et al. Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics[J]. Acta Neurochir (Wien), 2010,152(1):1-17.
|
| [20] |
Mondello S, Linnet A, Buki A, et al. Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury[J]. Neurosurgery, 2012, 70(3):666-675.
|
| [21] |
Papa L, Akinyi L, Liu MC, et al. Ubiquitin C- terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury[J].Crit Care Med,2010,38(1):138-144.
|
| [22] |
Liu MC, Akinyi L, Scharf D, et al. Ubiquitin C- terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats[J].Eur J Neurosci,2010,31(4):722-732.
|
| [23] |
Sultana R,Boyd-Kimball D,Cai J,et al.Proteomics analysis of the Alzheimer's disease hippocampal proteome[J].J Alzheimers Dis,2007,11(2):153-164.
|